Stason Animal Health, Inc. Selects Kansas City for Relocation of Corporate Headquarters

Kansas City, Kan. ” August 26, 2013 ” Stason Animal Health, Inc., a pharmaceutical company dedicated exclusively to the development of new chemical entities for companion animals, announced that it has selected Kansas City, Mo., part of the KC Animal Health Corridor, for its corporate headquarters.   The company will lease office space in the Bioscience & Technology Business Center located on the University of Kansas Medical Center campus.

Stason Animal Health (SAH) announced its decision tonight at the 8th annual KC Animal Health Corridor Homecoming dinner in Kansas City, one of the largest gatherings of animal health industry executives in the world.

“SAH chose to locate in Kansas City due to the available resources and personnel for animal health product development, as well as low operating costs and several incentive programs for new companies,” said Diana Wood, CEO.  “The culture of Kansas City and concentration of animal health companies here made the selection quite easy. There is no place like the KC Animal Health Corridor for a company looking to serve the animal health industry.”

Before selecting Kansas City, SAH was located in Vancouver, Washington.  The relocation was complete earlier this month.  The Kansas City Area Development Council represented the KC Animal Health Corridor in working with SAH. Other important partners include the Unified Government of Wyandotte County/Kansas City, Kansas, and the Kansas Department of Commerce.

Bob Marcusse, president and CEO of the Kansas City Area Development Council, said, “With the KC Animal Health Corridor’s globally unique animal health industry concentration offering a mix of companies, higher education, research and service providers, the Kansas City area is an ideal location for Stason Animal Health  to grow and succeed.”

About Stason Animal Health
Stason Animal Health (AHS) is an early stage company that offers a vertically integrated, value-added platform for new drug development.  Through its unique association with Stason Pharmaceuticals, Inc., located in Irvine, Cali., SAH has access to development, manufacturing, distribution, marketing and sales of the products it develops.  The company’s primary focus is the development of new chemical entities for companion animals.  SAH’s initial product is currently undergoing a proof of concept study at a leading veterinary research university.

About the KC Animal Health Corridor
The KC Animal Health Corridor is the home of the largest concentration of animal health industry assets in the world. Centered in the Kansas City area in the U.S. Midwest, the Corridor accounts for nearly one third of the sales for the global animal health industry. The Corridor is home to more than 300 animal health companies, employing at least 22,000 people.


Comments are closed.